350 related articles for article (PubMed ID: 32391790)
1. Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer.
Burfeind KG; Zhu X; Norgard MA; Levasseur PR; Huisman C; Buenafe AC; Olson B; Michaelis KA; Torres ER; Jeng S; McWeeney S; Raber J; Marks DL
Elife; 2020 May; 9():. PubMed ID: 32391790
[TBL] [Abstract][Full Text] [Related]
2. Targeting both tumour-associated CXCR2
Nywening TM; Belt BA; Cullinan DR; Panni RZ; Han BJ; Sanford DE; Jacobs RC; Ye J; Patel AA; Gillanders WE; Fields RC; DeNardo DG; Hawkins WG; Goedegebuure P; Linehan DC
Gut; 2018 Jun; 67(6):1112-1123. PubMed ID: 29196437
[TBL] [Abstract][Full Text] [Related]
3. CCR2 Expression in Neutrophils Plays a Critical Role in Their Migration Into the Joints in Rheumatoid Arthritis.
Talbot J; Bianchini FJ; Nascimento DC; Oliveira RD; Souto FO; Pinto LG; Peres RS; Silva JR; Almeida SC; Louzada-Junior P; Cunha TM; Cunha FQ; Alves-Filho JC
Arthritis Rheumatol; 2015 Jul; 67(7):1751-9. PubMed ID: 25779331
[TBL] [Abstract][Full Text] [Related]
4. Brain radiation injury leads to a dose- and time-dependent recruitment of peripheral myeloid cells that depends on CCR2 signaling.
Moravan MJ; Olschowka JA; Williams JP; O'Banion MK
J Neuroinflammation; 2016 Feb; 13():30. PubMed ID: 26842770
[TBL] [Abstract][Full Text] [Related]
5. MyD88 signalling is critical in the development of pancreatic cancer cachexia.
Zhu X; Burfeind KG; Michaelis KA; Braun TP; Olson B; Pelz KR; Morgan TK; Marks DL
J Cachexia Sarcopenia Muscle; 2019 Apr; 10(2):378-390. PubMed ID: 30666818
[TBL] [Abstract][Full Text] [Related]
6. The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy.
Zhong X; Pons M; Poirier C; Jiang Y; Liu J; Sandusky GE; Shahda S; Nakeeb A; Schmidt CM; House MG; Ceppa EP; Zyromski NJ; Liu Y; Jiang G; Couch ME; Koniaris LG; Zimmers TA
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1083-1101. PubMed ID: 31286691
[TBL] [Abstract][Full Text] [Related]
7. CCL2-CCR2 signaling promotes hepatic ischemia/reperfusion injury.
Zhang J; Xu P; Song P; Wang H; Zhang Y; Hu Q; Wang G; Zhang S; Yu Q; Billiar TR; Wang C; Zhang J
J Surg Res; 2016 May; 202(2):352-62. PubMed ID: 27229110
[TBL] [Abstract][Full Text] [Related]
8. CCR2 Signaling Promotes Brain Infiltration of Inflammatory Monocytes and Contributes to Neuropathology during Cryptococcal Meningoencephalitis.
Xu J; Ganguly A; Zhao J; Ivey M; Lopez R; Osterholzer JJ; Cho CS; Olszewski MA
mBio; 2021 Aug; 12(4):e0107621. PubMed ID: 34311579
[TBL] [Abstract][Full Text] [Related]
9. Analysis of monocyte infiltration in MPTP mice reveals that microglial CX3CR1 protects against neurotoxic over-induction of monocyte-attracting CCL2 by astrocytes.
Parillaud VR; Lornet G; Monnet Y; Privat AL; Haddad AT; Brochard V; Bekaert A; de Chanville CB; Hirsch EC; Combadière C; Hunot S; Lobsiger CS
J Neuroinflammation; 2017 Mar; 14(1):60. PubMed ID: 28320442
[TBL] [Abstract][Full Text] [Related]
10. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
[TBL] [Abstract][Full Text] [Related]
11. Myeloid NEMO deficiency promotes tumor immunosuppression partly via MCP1-CCR2 axis.
Yuanyuan L; Yakun L; Zhongyao L; Le Y; Weisong D; Moran G; Hui B; Chunyan L
Exp Cell Res; 2021 Feb; 399(2):112467. PubMed ID: 33428904
[TBL] [Abstract][Full Text] [Related]
12. Establishment and characterization of a novel murine model of pancreatic cancer cachexia.
Michaelis KA; Zhu X; Burfeind KG; Krasnow SM; Levasseur PR; Morgan TK; Marks DL
J Cachexia Sarcopenia Muscle; 2017 Oct; 8(5):824-838. PubMed ID: 28730707
[TBL] [Abstract][Full Text] [Related]
13. Infiltrating monocytes promote brain inflammation and exacerbate neuronal damage after status epilepticus.
Varvel NH; Neher JJ; Bosch A; Wang W; Ransohoff RM; Miller RJ; Dingledine R
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5665-74. PubMed ID: 27601660
[TBL] [Abstract][Full Text] [Related]
14. Neonatal Stroke and TLR1/2 Ligand Recruit Myeloid Cells through the Choroid Plexus in a CX3CR1-CCR2- and Context-Specific Manner.
Rayasam A; Faustino J; Lecuyer M; Vexler ZS
J Neurosci; 2020 May; 40(19):3849-3861. PubMed ID: 32269105
[TBL] [Abstract][Full Text] [Related]
15. Tumor-Derived CCL2 Mediates Resistance to Radiotherapy in Pancreatic Ductal Adenocarcinoma.
Kalbasi A; Komar C; Tooker GM; Liu M; Lee JW; Gladney WL; Ben-Josef E; Beatty GL
Clin Cancer Res; 2017 Jan; 23(1):137-148. PubMed ID: 27354473
[TBL] [Abstract][Full Text] [Related]
16. Molecular and cellular neuroinflammatory status of mouse brain after systemic lipopolysaccharide challenge: importance of CCR2/CCL2 signaling.
Cazareth J; Guyon A; Heurteaux C; Chabry J; Petit-Paitel A
J Neuroinflammation; 2014 Jul; 11():132. PubMed ID: 25065370
[TBL] [Abstract][Full Text] [Related]
17. Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin.
Zhong X; Narasimhan A; Silverman LM; Young AR; Shahda S; Liu S; Wan J; Liu Y; Koniaris LG; Zimmers TA
J Cachexia Sarcopenia Muscle; 2022 Aug; 13(4):2146-2161. PubMed ID: 35510530
[TBL] [Abstract][Full Text] [Related]
18. Role of MCP-1 and CCR2 in ethanol-induced neuroinflammation and neurodegeneration in the developing brain.
Zhang K; Wang H; Xu M; Frank JA; Luo J
J Neuroinflammation; 2018 Jul; 15(1):197. PubMed ID: 29976212
[TBL] [Abstract][Full Text] [Related]
19. Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model.
Teng KY; Han J; Zhang X; Hsu SH; He S; Wani NA; Barajas JM; Snyder LA; Frankel WL; Caligiuri MA; Jacob ST; Yu J; Ghoshal K
Mol Cancer Ther; 2017 Feb; 16(2):312-322. PubMed ID: 27980102
[TBL] [Abstract][Full Text] [Related]
20. Key role of the CCR2-CCL2 axis in disease modification in a mouse model of tauopathy.
Ben-Yehuda H; Arad M; Peralta Ramos JM; Sharon E; Castellani G; Ferrera S; Cahalon L; Colaiuta SP; Salame TM; Schwartz M
Mol Neurodegener; 2021 Jun; 16(1):39. PubMed ID: 34172073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
